Mucopolysaccharidosis VII Disease Monitoring Program
Part of paid clinical trials in Orange, California.
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Study ID
- NCT03604835
- Status
- Recruiting
Conditions
- MPS 7
- MPS VII
- Mucopolysaccharidosis VII
- Sly Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No Intervention — OTHERAccess to any treatment is through authorized commercial use or available expanded access programs only and not as a part of this DMP.
Study Details
The objectives of this study are to characterize MPS VII disease presentation and progression and assess long-term effectiveness and safety, including hypersensitivity reactions and immunogenicity of vestronidase alfa.
Key Dates
- Start date
- Jan 29, 2018
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2032
- Completion
- Apr 30, 2032
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Patients with MPS VII receiving vestronidase-alfavia prescription, or early access/ compassionate use program
- Arm: Patients with MPS VII not receiving vestronidase-alfano treatment or treatment other than vestronidase alfa
Primary Outcome Measure
Clinical Course of MPS VII Disease [ Time Frame: 10 years ]
Central Contacts
- Patients Contact: Trial Recruitment1-888-756-8657
- HCPs Contact: Medical Information1-888-756-8657
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Orange County | Orange | California | 92868 | - |
| Children's National Health System | Washington D.C. | District of Columbia | 20010 | - |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | - |
| University of Michigan | Ann Arbor | Michigan | 48109 | - |
| New York University Langone Medical Center | New York | New York | 10016 | - |
| University of Utah Medical Center | Salt Lake City | Utah | 84112 | - |
| Seattle Children's Hospital | Seattle | Washington | 98105 | - |
Find similar trials in Orange, CA
By research site
Children's Hospital of Orange County· Orange, CAChildren's National Health System· Washington D.C., DCAnn & Robert H. Lurie Children's Hospital of Chicago· Chicago, ILUniversity of Michigan· Ann Arbor, MINew York University Langone Medical Center· New York, NYUniversity of Utah Medical Center· Salt Lake City, UT
Related Studies
- PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)PHASE1 · Recruiting · University of California, San Francisco · San Francisco, California
- ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramEnrolling By Invitation · Albert Einstein College of Medicine · Brooklyn, New York
- Registry of Patients Diagnosed With Lysosomal Storage DiseasesRecruiting · University of California, San Francisco · San Francisco, California